Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lb Pharmaceuticals Inc.

Clinical trials sponsored by Lb Pharmaceuticals Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for schizophrenia: phase 3 drug trial begins Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Completed 1

New schizophrenia drug shows promise in early trial

Disease control Completed

This study tested a new drug called LB-102 in 359 adults with acute schizophrenia. Participants received either LB-102 or a placebo for 28 days. The goal was to see if LB-102 reduces symptoms like hallucinations and confusion better than a placebo. The trial is now complete, and …

Phase 2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC